Shares of Danaher Corporation (NYSE:DHR) have received an average recommendation of “Buy” from the eighteen research firms that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. The average 12-month target price among brokers that have covered the stock in the last year is $92.39.

DHR has been the topic of a number of recent analyst reports. Vetr raised Danaher Corporation from a “buy” rating to a “strong-buy” rating and set a $94.18 price target on the stock in a research report on Thursday, April 20th. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $88.00 target price (down previously from $89.00) on shares of Danaher Corporation in a research report on Friday, April 21st. Zacks Investment Research downgraded Danaher Corporation from a “buy” rating to a “hold” rating in a research report on Friday, April 21st. BTIG Research reaffirmed a “buy” rating and issued a $92.00 target price on shares of Danaher Corporation in a research report on Sunday, April 23rd. Finally, Cowen and Company reaffirmed an “outperform” rating and issued a $90.00 target price on shares of Danaher Corporation in a research report on Sunday, April 23rd.

In related news, Director Linda P. Hefner sold 10,578 shares of the stock in a transaction on Friday, July 21st. The stock was sold at an average price of $83.03, for a total value of $878,291.34. Following the completion of the sale, the director now directly owns 42,151 shares in the company, valued at $3,499,797.53. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Angela S. Lalor sold 10,815 shares of the stock in a transaction on Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total value of $910,190.40. Following the completion of the sale, the senior vice president now owns 39,020 shares of the company’s stock, valued at $3,283,923.20. The disclosure for this sale can be found here. Insiders have sold 38,623 shares of company stock valued at $3,206,426 over the last quarter. Company insiders own 12.20% of the company’s stock.

Hedge funds have recently modified their holdings of the company. Israel Discount Bank of New York GFN acquired a new stake in shares of Danaher Corporation during the fourth quarter worth $225,000. Vident Investment Advisory LLC increased its stake in shares of Danaher Corporation by 5.4% in the fourth quarter. Vident Investment Advisory LLC now owns 29,689 shares of the conglomerate’s stock worth $2,311,000 after buying an additional 1,521 shares during the last quarter. Aristotle Capital Management LLC increased its stake in shares of Danaher Corporation by 4.5% in the fourth quarter. Aristotle Capital Management LLC now owns 2,771,135 shares of the conglomerate’s stock worth $215,705,000 after buying an additional 119,978 shares during the last quarter. Norges Bank acquired a new stake in shares of Danaher Corporation during the fourth quarter worth $465,363,000. Finally, Putnam Investments LLC increased its stake in shares of Danaher Corporation by 17.0% in the fourth quarter. Putnam Investments LLC now owns 3,721,935 shares of the conglomerate’s stock worth $289,715,000 after buying an additional 540,529 shares during the last quarter. Hedge funds and other institutional investors own 76.56% of the company’s stock.

Danaher Corporation (DHR) opened at 80.27 on Friday. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.01. The firm has a 50 day moving average price of $83.66 and a 200-day moving average price of $84.23. The firm has a market capitalization of $55.76 billion, a price-to-earnings ratio of 25.62 and a beta of 1.03.

Danaher Corporation (NYSE:DHR) last announced its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.97 by $0.02. The firm had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The business’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.90 earnings per share. On average, equities analysts forecast that Danaher Corporation will post $3.95 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Brokerages Set Danaher Corporation (DHR) Target Price at $92.28” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another website, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/09/danaher-corporation-dhr-receives-consensus-recommendation-of-buy-from-analysts-updated-updated-updated.html.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Analyst Recommendations for Danaher Corporation (NYSE:DHR)

Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.